LKH Graz II, Standort Süd

The medical center is at the forefront of psychiatry and mental health research, focusing on innovative treatments for complex conditions. A key area of study is the exploration of novel therapeutic agents for treatment-resistant depression.

• Psilocybin Therapy
• Advanced Depression Treatments
• Neuropsychiatric Research

Through rigorous clinical trials, the center is evaluating the therapeutic efficacy of psilocybin, aiming to provide new hope for patients who have not responded to traditional treatments. This research not only contributes to the understanding of depression but also paves the way for groundbreaking clinical applications.